Global High-throughput 3D Bioprinter Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global High-throughput 3D Bioprinter Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Contact 3D Printing
- 1.3.3 Non-contact 3D Printing
- 1.4 Market Analysis by Form
- 1.4.1 Overview: Global High-throughput 3D Bioprinter Consumption Value by Form: 2021 Versus 2025 Versus 2032
- 1.4.2 Desktop Type
- 1.4.3 Standing Type
- 1.5 Market Analysis by Bioprinting Technology
- 1.5.1 Overview: Global High-throughput 3D Bioprinter Consumption Value by Bioprinting Technology: 2021 Versus 2025 Versus 2032
- 1.5.2 Extrusion-based
- 1.5.3 Inkjet-based
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global High-throughput 3D Bioprinter Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hosptial
- 1.6.3 University
- 1.6.4 Laboratory
- 1.6.5 Others
- 1.7 Global High-throughput 3D Bioprinter Market Size & Forecast
- 1.7.1 Global High-throughput 3D Bioprinter Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global High-throughput 3D Bioprinter Sales Quantity (2021-2032)
- 1.7.3 Global High-throughput 3D Bioprinter Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 BICO
- 2.1.1 BICO Details
- 2.1.2 BICO Major Business
- 2.1.3 BICO High-throughput 3D Bioprinter Product and Services
- 2.1.4 BICO High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 BICO Recent Developments/Updates
- 2.2 CORNING
- 2.2.1 CORNING Details
- 2.2.2 CORNING Major Business
- 2.2.3 CORNING High-throughput 3D Bioprinter Product and Services
- 2.2.4 CORNING High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 CORNING Recent Developments/Updates
- 2.3 PrintBio
- 2.3.1 PrintBio Details
- 2.3.2 PrintBio Major Business
- 2.3.3 PrintBio High-throughput 3D Bioprinter Product and Services
- 2.3.4 PrintBio High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 PrintBio Recent Developments/Updates
- 2.4 REGEMAT 3D
- 2.4.1 REGEMAT 3D Details
- 2.4.2 REGEMAT 3D Major Business
- 2.4.3 REGEMAT 3D High-throughput 3D Bioprinter Product and Services
- 2.4.4 REGEMAT 3D High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 REGEMAT 3D Recent Developments/Updates
- 2.5 Inventia Life Science
- 2.5.1 Inventia Life Science Details
- 2.5.2 Inventia Life Science Major Business
- 2.5.3 Inventia Life Science High-throughput 3D Bioprinter Product and Services
- 2.5.4 Inventia Life Science High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Inventia Life Science Recent Developments/Updates
- 2.6 GeSiM
- 2.6.1 GeSiM Details
- 2.6.2 GeSiM Major Business
- 2.6.3 GeSiM High-throughput 3D Bioprinter Product and Services
- 2.6.4 GeSiM High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 GeSiM Recent Developments/Updates
- 2.7 Poietis
- 2.7.1 Poietis Details
- 2.7.2 Poietis Major Business
- 2.7.3 Poietis High-throughput 3D Bioprinter Product and Services
- 2.7.4 Poietis High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Poietis Recent Developments/Updates
- 2.8 Cyfuse
- 2.8.1 Cyfuse Details
- 2.8.2 Cyfuse Major Business
- 2.8.3 Cyfuse High-throughput 3D Bioprinter Product and Services
- 2.8.4 Cyfuse High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Cyfuse Recent Developments/Updates
- 2.9 Allevi(3D Systems)
- 2.9.1 Allevi(3D Systems) Details
- 2.9.2 Allevi(3D Systems) Major Business
- 2.9.3 Allevi(3D Systems) High-throughput 3D Bioprinter Product and Services
- 2.9.4 Allevi(3D Systems) High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Allevi(3D Systems) Recent Developments/Updates
- 2.10 Advanced Solutions
- 2.10.1 Advanced Solutions Details
- 2.10.2 Advanced Solutions Major Business
- 2.10.3 Advanced Solutions High-throughput 3D Bioprinter Product and Services
- 2.10.4 Advanced Solutions High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Advanced Solutions Recent Developments/Updates
- 2.11 Hangzhou Regenovo Biotechnology
- 2.11.1 Hangzhou Regenovo Biotechnology Details
- 2.11.2 Hangzhou Regenovo Biotechnology Major Business
- 2.11.3 Hangzhou Regenovo Biotechnology High-throughput 3D Bioprinter Product and Services
- 2.11.4 Hangzhou Regenovo Biotechnology High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Hangzhou Regenovo Biotechnology Recent Developments/Updates
- 2.12 Sai Foil (Shanghai) Biotechnology
- 2.12.1 Sai Foil (Shanghai) Biotechnology Details
- 2.12.2 Sai Foil (Shanghai) Biotechnology Major Business
- 2.12.3 Sai Foil (Shanghai) Biotechnology High-throughput 3D Bioprinter Product and Services
- 2.12.4 Sai Foil (Shanghai) Biotechnology High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Sai Foil (Shanghai) Biotechnology Recent Developments/Updates
- 2.13 Shanghai Prismlab
- 2.13.1 Shanghai Prismlab Details
- 2.13.2 Shanghai Prismlab Major Business
- 2.13.3 Shanghai Prismlab High-throughput 3D Bioprinter Product and Services
- 2.13.4 Shanghai Prismlab High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Shanghai Prismlab Recent Developments/Updates
- 2.14 Suzhou ELF Group
- 2.14.1 Suzhou ELF Group Details
- 2.14.2 Suzhou ELF Group Major Business
- 2.14.3 Suzhou ELF Group High-throughput 3D Bioprinter Product and Services
- 2.14.4 Suzhou ELF Group High-throughput 3D Bioprinter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Suzhou ELF Group Recent Developments/Updates
3 Competitive Environment: High-throughput 3D Bioprinter by Manufacturer
- 3.1 Global High-throughput 3D Bioprinter Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global High-throughput 3D Bioprinter Revenue by Manufacturer (2021-2026)
- 3.3 Global High-throughput 3D Bioprinter Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of High-throughput 3D Bioprinter by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 High-throughput 3D Bioprinter Manufacturer Market Share in 2025
- 3.4.3 Top 6 High-throughput 3D Bioprinter Manufacturer Market Share in 2025
- 3.5 High-throughput 3D Bioprinter Market: Overall Company Footprint Analysis
- 3.5.1 High-throughput 3D Bioprinter Market: Region Footprint
- 3.5.2 High-throughput 3D Bioprinter Market: Company Product Type Footprint
- 3.5.3 High-throughput 3D Bioprinter Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global High-throughput 3D Bioprinter Market Size by Region
- 4.1.1 Global High-throughput 3D Bioprinter Sales Quantity by Region (2021-2032)
- 4.1.2 Global High-throughput 3D Bioprinter Consumption Value by Region (2021-2032)
- 4.1.3 Global High-throughput 3D Bioprinter Average Price by Region (2021-2032)
- 4.2 North America High-throughput 3D Bioprinter Consumption Value (2021-2032)
- 4.3 Europe High-throughput 3D Bioprinter Consumption Value (2021-2032)
- 4.4 Asia-Pacific High-throughput 3D Bioprinter Consumption Value (2021-2032)
- 4.5 South America High-throughput 3D Bioprinter Consumption Value (2021-2032)
- 4.6 Middle East & Africa High-throughput 3D Bioprinter Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global High-throughput 3D Bioprinter Sales Quantity by Type (2021-2032)
- 5.2 Global High-throughput 3D Bioprinter Consumption Value by Type (2021-2032)
- 5.3 Global High-throughput 3D Bioprinter Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global High-throughput 3D Bioprinter Sales Quantity by Application (2021-2032)
- 6.2 Global High-throughput 3D Bioprinter Consumption Value by Application (2021-2032)
- 6.3 Global High-throughput 3D Bioprinter Average Price by Application (2021-2032)
7 North America
- 7.1 North America High-throughput 3D Bioprinter Sales Quantity by Type (2021-2032)
- 7.2 North America High-throughput 3D Bioprinter Sales Quantity by Application (2021-2032)
- 7.3 North America High-throughput 3D Bioprinter Market Size by Country
- 7.3.1 North America High-throughput 3D Bioprinter Sales Quantity by Country (2021-2032)
- 7.3.2 North America High-throughput 3D Bioprinter Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe High-throughput 3D Bioprinter Sales Quantity by Type (2021-2032)
- 8.2 Europe High-throughput 3D Bioprinter Sales Quantity by Application (2021-2032)
- 8.3 Europe High-throughput 3D Bioprinter Market Size by Country
- 8.3.1 Europe High-throughput 3D Bioprinter Sales Quantity by Country (2021-2032)
- 8.3.2 Europe High-throughput 3D Bioprinter Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific High-throughput 3D Bioprinter Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific High-throughput 3D Bioprinter Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific High-throughput 3D Bioprinter Market Size by Region
- 9.3.1 Asia-Pacific High-throughput 3D Bioprinter Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific High-throughput 3D Bioprinter Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America High-throughput 3D Bioprinter Sales Quantity by Type (2021-2032)
- 10.2 South America High-throughput 3D Bioprinter Sales Quantity by Application (2021-2032)
- 10.3 South America High-throughput 3D Bioprinter Market Size by Country
- 10.3.1 South America High-throughput 3D Bioprinter Sales Quantity by Country (2021-2032)
- 10.3.2 South America High-throughput 3D Bioprinter Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa High-throughput 3D Bioprinter Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa High-throughput 3D Bioprinter Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa High-throughput 3D Bioprinter Market Size by Country
- 11.3.1 Middle East & Africa High-throughput 3D Bioprinter Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa High-throughput 3D Bioprinter Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 High-throughput 3D Bioprinter Market Drivers
- 12.2 High-throughput 3D Bioprinter Market Restraints
- 12.3 High-throughput 3D Bioprinter Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of High-throughput 3D Bioprinter and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of High-throughput 3D Bioprinter
- 13.3 High-throughput 3D Bioprinter Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 High-throughput 3D Bioprinter Typical Distributors
- 14.3 High-throughput 3D Bioprinter Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global High-throughput 3D Bioprinter market size was valued at US$ 523 million in 2025 and is forecast to a readjusted size of US$ 1016 million by 2032 with a CAGR of 10.1% during review period.
A high-throughput 3D bioprinter is a high-efficiency 3D printing system specifically used in the biomedical field. It can quickly produce a large number of cell or tissue samples in a short period of time, and is suitable for high-throughput screening and complex structure modeling. By integrating multiple print heads and precise control systems, the device can print multiple independent samples simultaneously or one by one, improving experimental efficiency. Its advantages lie in greatly shortening the research cycle and reducing experimental resource consumption, while providing high flexibility and repeatability, helping to rapidly advance biomedical innovation and drug research and development. In 2025, global High-throughput 3D Bioprinter production reached approximately 8612 units with an average global market price of around k US$59 per unit.
High-throughput 3D bioprinters represent a significant advancement in biofabrication technology, enabling the rapid production of complex biological structures at an unprecedented scale. These systems are designed to overcome the limitations of traditional bioprinting by incorporating multiple printheads and automated workflows, such as the Bio X system equipped with three "intelligent" printhead mounts, allowing simultaneous printing of multiple tissue constructs with different bioinks. The integration of advanced features like temperature-controlled printbeds, UV-C germicidal lamps, HEPA H14 dual-filter systems, and exchangeable photocuring modules ensures consistent print quality while maintaining cell viability across large production runs. By dramatically reducing production time from hours to minutes per construct, high-throughput bioprinters facilitate the transition from laboratory-scale research to industrial-scale manufacturing of personalized tissues and organs, addressing critical bottlenecks in regenerative medicine and drug discovery.
This report is a detailed and comprehensive analysis for global High-throughput 3D Bioprinter market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global High-throughput 3D Bioprinter market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global High-throughput 3D Bioprinter market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global High-throughput 3D Bioprinter market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global High-throughput 3D Bioprinter market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High-throughput 3D Bioprinter
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global High-throughput 3D Bioprinter market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BICO, CORNING, PrintBio, REGEMAT 3D, Inventia Life Science, GeSiM, Poietis, Cyfuse, Allevi(3D Systems), Advanced Solutions, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
High-throughput 3D Bioprinter market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Contact 3D Printing
Non-contact 3D Printing
Market segment by Form
Desktop Type
Standing Type
Market segment by Bioprinting Technology
Extrusion-based
Inkjet-based
Market segment by Application
Hosptial
University
Laboratory
Others
Major players covered
BICO
CORNING
PrintBio
REGEMAT 3D
Inventia Life Science
GeSiM
Poietis
Cyfuse
Allevi(3D Systems)
Advanced Solutions
Hangzhou Regenovo Biotechnology
Sai Foil (Shanghai) Biotechnology
Shanghai Prismlab
Suzhou ELF Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High-throughput 3D Bioprinter product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of High-throughput 3D Bioprinter, with price, sales quantity, revenue, and global market share of High-throughput 3D Bioprinter from 2021 to 2026.
Chapter 3, the High-throughput 3D Bioprinter competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High-throughput 3D Bioprinter breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and High-throughput 3D Bioprinter market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of High-throughput 3D Bioprinter.
Chapter 14 and 15, to describe High-throughput 3D Bioprinter sales channel, distributors, customers, research findings and conclusion.